At a recent meeting in Boston, representatives from global pharmaceutical companies gathered to discuss how to transition from batch to continuous manufacturing. And what company better to learn from ...
Transform the production of oral solid dosage forms in the pharmaceutical industry with L.B. Bohle. L.B. Bohle supports companies with their machines and processes in adopting Continuous Manufacturing ...
Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...
New drug discovery is the foundation of the pharma industry’s search for novel therapeutics that are safe to treat life-threatening diseases. Pharmaceutical manufacturers are continuously challenged ...
The biopharmaceutical industry has seen substantial growth in recent years, generating novel biotherapeutics and biosimilars at an unprecedented rate. One of the biggest challenges in the industry is ...
Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...
Indian pharma sees immense relevance to US FDA Continuous Manufacturing norms as companies shift from batch production, which is multi-step and a lengthy process, to a quicker, and resourceful process ...
The antibiotic cefazolin is an essential drug according to the World Health Organization (WHO). It is usually produced via batch manufacturing, but this multistep process is time-consuming, wasteful ...
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Continuous Manufacturing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Continuous ...
Vertex Pharmaceuticals ($VRTX) is building a $30 million, 4,000-square-foot continuous manufacturing facility in Boston in anticipation that it will get approval for ...
Continued process verification (CPV) is the third stage of the product lifecycle of any medicine either within the small or large molecule arena. The CPV is the subsequent step to process design ...
“It’s called a BHAG,” says Hayden Thomas, divulging a term popular among chemical engineers at Vertex Pharmaceuticals, where Thomas is vice president of formulation development. “A big, hairy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback